Anatara Lifesciences Ltd (ASX:ANR)
0.0120
-0.0020 (-14.29%)
Jan 30, 2026, 3:06 PM AEST
Anatara Lifesciences Revenue
In the fiscal year ending June 30, 2025, Anatara Lifesciences had annual revenue of 969.46K AUD with 50.53% growth. Anatara Lifesciences had revenue of 446.20K in the half year ending June 30, 2025.
Revenue
969.46K
Revenue Growth
+50.53%
P/S Ratio
4.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 969.46K | 325.43K | 50.53% |
| Jun 30, 2024 | 644.03K | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 12.68M |
| Immuron | 7.29M |
| Biotron | 1.81M |
| Acrux | 1.19M |
| InhaleRx | 833.90K |
| Patrys | 828.54K |
| AdAlta | 677.01K |
| Bio-Gene Technology | 524.37K |